Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Iclaprim

Generic Name: Iclaprim

Drug Type: Small Molecule

Chemical Formula: C_₁₉H_₂₂N_₄O_₃

CAS Number: 192314-93-5

Unique Ingredient Identifier: 42445HUU0O

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in bacterial infection, skin infections/disorders, obesity, liver disease, kidney disease, and pneumonia.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

Phase 3

Completed

Posted: 2015/11/18

Sponsor:

Motif Bio

ID:NCT02607618

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Phase 3

Completed

Posted: 2015/11/09

Sponsor:

Motif Bio

ID:NCT02600611

Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia

Phase 2

Terminated

Posted: 2007/10/15

Sponsor:Arpida AG

ID:NCT00543608

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Phase 3

Completed

Posted: 2006/03/17

Sponsor:Arpida AG

ID:NCT00303550

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy